secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2026-06-26T20:05:43+00:00
Accession:  0001213900-26-072602
Event type: debt
Sentiment:  negative
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics enters amended convertible note for $1.4M; conversion price floor $0.05, 10% interest
--------------------------------------------------------------------------------

- Amended and restated promissory note with SRX Health Solutions for up to $1,413,600; $663,600 funded on June 23, 2026, on top of $750,000 from May 28 note.
- Note bears 10% annual interest, matures May 28, 2027; convertible into common stock at the lesser of $0.05 or 80% of avg of 5 lowest intraday prices in prior 20 days.
- Conversion subject to 4.99% beneficial ownership limitation; Company to file resale registration statement for shares issuable upon conversion.
- Issuance exempt from registration under Section 4(a)(2) and Rule 506(b); Note and underlying shares unregistered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390026072602/0001213900-26-072602-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390026072602/ea0296022-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-072602

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer